Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04415684 · ClinicalTrials.gov registry record · NA
Projected Peripheral Defocus Using a Wearable Device
A NA study, sponsored by Kubota Vision.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04415684: Completed NA study, sponsored by Kubota Vision.
NCT04415684 is a NA study that has completed, run by Kubota Vision. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04415684, a NA study, has completed, sponsored by Kubota Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery utilizing a wearable device will stimulate physiological changes similar to those in the literature.
Primary Outcome
Change in AL from baseline in the test eye vs. control eye
Interventions
- DEVICE Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
- DEVICE No Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2020-08-20 |
| Phase | NA |
What the finished NCT04415684 record still lists
NCT04415684 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.) is the first listed.
NCT04415684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04415684 about?
NCT04415684 is a clinical study titled "Projected Peripheral Defocus Using a Wearable Device". Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimped...
What is the current status of trial NCT04415684?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-06-29. Estimated completion is 2020-08-20.
What interventions are being tested in trial NCT04415684?
The interventions under investigation include: Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.) (DEVICE), No Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.) (DEVICE).
Who is sponsoring clinical trial NCT04415684?
This trial is sponsored by Kubota Vision, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04415684's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI